Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Cardiology

  • 1
    News

    Simvastatin, atorvastatin cut mortality risk for sepsis patients

    April 9, 2018

    In addition to supporting cardiac function and inhibiting inflammatory cytokines, these statins appear to exert a direct antimicrobial effect.

  • 1
    News

    Use of a risk score may be able to identify high-risk patients presenting with acute heart failure

    April 9, 2018

    Clinical question: Can we use readily available data to risk stratify patients who present to the emergency department in acute heart failure (AHF)?

  • 1
    News

    Percutaneous coronary intervention (PCI) does not improve exercise time in patients with stable angina

    April 5, 2018

    Does PCI provide symptom relief in patients with stable angina?

  • 1
    News

    Any detectable high-sensitivity cardiac troponin T (hs-cTn) level is associated with adverse outcomes

    April 4, 2018

    What is the association between high-sensitivity cardiac troponin T (hs-cTn) levels and outcomes in patients with chest pain?

  • 1
    News

    Warfarin dose capping avoided supratherapeutic INRs in hospitalized elderly

    March 30, 2018

    SAN DIEGO – Limiting the initial dose of warfarin to 2.5 mg or less for hospitalized patients aged 85 years and older led to significant reductions in supratherapeutic INRs.

  • 1
    News

    Major message: Most heart failure is preventable

    March 26, 2018

    SNOWMASS, COLO. – Targeting heart failure’s chief risk factors pays off.

  • 1
    News

    Top hospital heart failure performance translates to longer survival

    March 24, 2018

    ORLANDO – Get With the Guidelines data show that quality hospital care lengthens lives.

  • 1
    Video

    VIDEO: Andexanet alfa effectively reverses factor Xa anticoagulant 

    March 21, 2018

    ORLANDO – Now that reversal is possible prescriptions for the already-popular direct Factor Xa inhibitor, anticoagulants should spike higher.

  • 1
    News

    Beware of polypharmacy in patients taking warfarin

    March 20, 2018

    SAN DIEGO – The incidence of polypharmacy among patients on warfarin therapy appears to peak at age 75.

  • News

    DOACs may be beneficial in post-op atrial fib after CABG

    March 17, 2018

    The use of direct oral anticoagulants were not significantly different from warfarin for safety and efficacy in cases of post-op atrial fib following coronary artery bypass grafting.

Previous1 … 60 61 62 63 64 … 79Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences